No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
No Data
JonesTrading Maintains Curis(CRIS.US) With Buy Rating, Maintains Target Price $12
Curis's Strategic Clinical Advancements and Positive Regulatory Feedback Underpin Buy Rating
Truist Financial Maintains Curis(CRIS.US) With Buy Rating
Analysts Offer Insights on Healthcare Companies: Curis (CRIS), Ardent Health Partners, Inc. (ARDT) and Agilon Health (AGL)
Curis Inc. Earnings Call: Clinical Advances Amid Cash Concerns
Express News | Curis Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)